.png)
Retinal Biosimilars Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : September 2019 Pages : 160 Category: Medical Devices Report Code : HC095981
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Retinal Biosimilars Market By Type (Macular Degeneration Drugs, Diabetic Eye Disease Drugs, Macular Pucker Drugs and Others) and Application (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Retinal Biosimilars Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. The growing prevalence and recurrence of retinal diseases is expected to be the major factor driving the growth of the retinal biosimilars market over the coming years. Various initiatives conducted by different organizations across the globe spread awareness related to the treatment and diagnosis of ophthalmic diseases. The International Centre for Eye Health (ICEH) focuses on spreading awareness regarding eye health anomalies and treatment.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Retinal Biosimilars Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Novartis (Sandoz)
- Shire
- Bayer
- Genentech
- Pfenex
- Reliance Life Sciences
- Hetero Drugs
- Intas Pharmaceuticals
- Santo Holding
- Regeneron Pharmaceuticals
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Retinal Biosimilars Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Macular Degeneration Drugs
o Diabetic Eye Disease Drugs
o Macular Pucker Drugs and Others
· Retinal Biosimilars Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
· Retinal Biosimilars Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Novartis (Sandoz)
o Shire
o Bayer
o Genentech
o Pfenex
o Reliance Life Sciences
o Hetero Drugs
o Intas Pharmaceuticals
o Santo Holding
o Regeneron Pharmaceuticals
· Retinal Biosimilars Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Retinal Biosimilars Market, By Country
o U.S. Retinal Biosimilars Market
o Canada Retinal Biosimilars Market
o Mexico Retinal Biosimilars Market
o Europe
§ Europe Retinal Biosimilars Market, By Country
o Germany Retinal Biosimilars Market
o UK Retinal Biosimilars Market
o France Retinal Biosimilars Market
o Russia Retinal Biosimilars Market
o Italy Retinal Biosimilars Market
o Rest of Europe Retinal Biosimilars Market
o Asia-Pacific
§ Asia-Pacific Retinal Biosimilars Market, By Country
o China Retinal Biosimilars Market
o Japan Retinal Biosimilars Market
o South Korea Retinal Biosimilars Market
o India Retinal Biosimilars Market
o Southeast Asia Retinal Biosimilars Market
o Rest of Asia-Pacific Retinal Biosimilars Market
o South America
§ South America Retinal Biosimilars Market
o Brazil Retinal Biosimilars Market
o Argentina Retinal Biosimilars Market
o Columbia Retinal Biosimilars Market
o Rest of South America Retinal Biosimilars Market
o Middle East and Africa
§ Middle East and Africa Retinal Biosimilars Market
o Saudi Arabia Retinal Biosimilars Market
o UAE Retinal Biosimilars Market
o Egypt Retinal Biosimilars Market
o Nigeria Retinal Biosimilars Market
o South Africa Retinal Biosimilars Market
o Rest of MEA Retinal Biosimilars Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Retinal Biosimilars Market, By Type
5.1. Introduction
5.2. Global Retinal Biosimilars Revenue and Market Share by Type (2017-2027)
5.2.1. Global Retinal Biosimilars Revenue and Revenue Share by Type (2017-2027)
5.3. Macular Degeneration Drugs
5.3.1. Global Macular Degeneration Drugs Revenue and Growth Rate (2017-2027)
5.4. Diabetic Eye Disease Drugs
5.4.1. Global Diabetic Eye Disease Drugs Revenue and Growth Rate (2017-2027)
5.5. Macular Pucker Drugs and Others
5.5.1. Global Macular Pucker Drugs and Others Revenue and Growth Rate (2017-2027)
6. Retinal Biosimilars Market, By Application
6.1. Introduction
6.2. Global Retinal Biosimilars Revenue and Market Share by Application (2017-2027)
6.2.1. Global Retinal Biosimilars Revenue and Revenue Share by Application (2017-2027)
6.3. Hospital Pharmacies
6.3.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)
6.4. Retail Pharmacies
6.4.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)
6.5. Online Pharmacies
6.5.1. Global Online Pharmacies Revenue and Growth Rate (2017-2027)
7. Retinal Biosimilars Market, By Region
7.1. Introduction
7.2. Global Retinal Biosimilars Revenue and Market Share by Regions
7.2.1. Global Retinal Biosimilars Revenue by Regions (2017-2027)
7.3. North America Retinal Biosimilars by Countries
7.3.1. North America Retinal Biosimilars Revenue and Growth Rate (2017-2027)
7.3.2. North America Retinal Biosimilars Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Retinal Biosimilars by Countries
7.4.1. Europe Retinal Biosimilars Revenue and Growth Rate (2017-2027)
7.4.2. Europe Retinal Biosimilars Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Retinal Biosimilars by Countries
7.5.1. Asia-Pacific Retinal Biosimilars Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Retinal Biosimilars Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Retinal Biosimilars by Countries
7.6.1. South America Retinal Biosimilars Revenue and Growth Rate (2017-2027)
7.6.2. South America Retinal Biosimilars Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Retinal Biosimilars by Countries
7.7.1. Middle East and Africa Retinal Biosimilars Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Retinal Biosimilars Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Novartis (Sandoz)
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Shire
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Bayer
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Genentech
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Pfenex
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Reliance Life Sciences
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Hetero Drugs
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Intas Pharmaceuticals
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Santo Holding
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Regeneron Pharmaceuticals
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Retinal Biosimilars Market Forecast (2017-2027)
9.1. Global Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Retinal Biosimilars Market Forecast by Regions (2017-2027)
9.2.1. North America Retinal Biosimilars Market Forecast (2017-2027)
9.2.1.1. United States Retinal Biosimilars Market Forecast (2017-2027)
9.2.1.2. Canada Retinal Biosimilars Market Forecast (2017-2027)
9.2.1.3. Mexico Retinal Biosimilars Market Forecast (2017-2027)
9.2.2. Europe Retinal Biosimilars Market Forecast (2017-2027)
9.2.2.1. Germany Retinal Biosimilars Market Forecast (2017-2027)
9.2.2.2. France Retinal Biosimilars Market Forecast (2017-2027)
9.2.2.3. UK Retinal Biosimilars Market Forecast (2017-2027)
9.2.2.4. Russia Retinal Biosimilars Market Forecast (2017-2027)
9.2.2.5. Italy Retinal Biosimilars Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Retinal Biosimilars Market Forecast (2017-2027)
9.2.3. Asia-Pacific Retinal Biosimilars Market Forecast (2017-2027)
9.2.3.1. China Retinal Biosimilars Market Forecast (2017-2027)
9.2.3.2. Japan Retinal Biosimilars Market Forecast (2017-2027)
9.2.3.3. Korea Retinal Biosimilars Market Forecast (2017-2027)
9.2.3.4. India Retinal Biosimilars Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Retinal Biosimilars Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Retinal Biosimilars Market Forecast (2017-2027)
9.2.4. South America Retinal Biosimilars Market Forecast (2017-2027)
9.2.4.1. Brazil Retinal Biosimilars Market Forecast (2017-2027)
9.2.4.2. Argentina Retinal Biosimilars Market Forecast (2017-2027)
9.2.4.3. Columbia Retinal Biosimilars Market Forecast (2017-2027)
9.2.4.4. Rest of South America Retinal Biosimilars Market Forecast (2017-2027)
9.2.5. Middle East and Africa Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.3. Egypt Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.4. Nigeria Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.5. South Africa Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.6. Turkey Retinal Biosimilars Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Retinal Biosimilars Market Forecast (2017-2027)
9.3. Retinal Biosimilars Market Forecast by Type (2017-2027)
9.3.1. Retinal Biosimilars Forecast by Type (2017-2027)
9.3.2. Retinal Biosimilars Market Share Forecast by Type (2017-2027)
9.4. Retinal Biosimilars Market Forecast by Application (2017-2027)
9.4.1. Retinal Biosimilars Forecast by Application (2017-2027)
9.4.2. Retinal Biosimilars Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Retinal Biosimilars Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Retinal Biosimilars Revenue and Revenue Share by Type (2017-2018)
Figure Global Macular Degeneration Drugs Revenue and Growth Rate (2017-2018)
Figure Global Diabetic Eye Disease Drugs Revenue and Growth Rate (2017-2018)
Figure Global Macular Pucker Drugs and Others Revenue and Growth Rate (2017-2018)
Table Global Retinal Biosimilars Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Retinal Biosimilars Revenue by Regions (2017-2018)
Figure North America Retinal Biosimilars Growth Rate (2017-2018)
Figure North America Retinal Biosimilars Revenue and Growth Rate (2017-2018)
Figure North America Retinal Biosimilars by Countries (2017-2018)
Figure North America Retinal Biosimilars Revenue (Million USD) by Countries (2017-2018)
Figure United States Retinal Biosimilars Growth Rate (2017-2018)
Figure United States Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Retinal Biosimilars Growth Rate (2017-2018)
Figure Canada Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Retinal Biosimilars Growth Rate (2017-2018)
Figure Mexico Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Retinal Biosimilars Growth Rate (2017-2018)
Figure Europe Retinal Biosimilars Revenue and Growth Rate (2017-2018)
Figure Europe Retinal Biosimilars by Countries (2017-2018)
Figure Europe Retinal Biosimilars Revenue (Million USD) by Countries (2017-2018)
Figure Germany Retinal Biosimilars Growth Rate (2017-2018)
Figure Germany Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Retinal Biosimilars Growth Rate (2017-2018)
Figure France Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Retinal Biosimilars Growth Rate (2017-2018)
Figure UK Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Retinal Biosimilars Growth Rate (2017-2018)
Figure Russia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Retinal Biosimilars Growth Rate (2017-2018)
Figure Italy Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Retinal Biosimilars Growth Rate (2017-2018)
Figure Rest of Europe Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Retinal Biosimilars Growth Rate (2017-2018)
Figure Asia-Pacific Retinal Biosimilars Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Retinal Biosimilars by Countries (2017-2018)
Figure Asia-Pacific Retinal Biosimilars Revenue (Million USD) by Countries (2017-2018)
Figure China Retinal Biosimilars Growth Rate (2017-2018)
Figure China Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Retinal Biosimilars Growth Rate (2017-2018)
Figure Japan Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Retinal Biosimilars Growth Rate (2017-2018)
Figure Korea Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Retinal Biosimilars Growth Rate (2017-2018)
Figure India Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Retinal Biosimilars Growth Rate (2017-2018)
Figure Southeast Asia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Retinal Biosimilars Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Retinal Biosimilars Growth Rate (2017-2018)
Figure South America Retinal Biosimilars Revenue and Growth Rate (2017-2018)
Figure South America Retinal Biosimilars by Countries (2017-2018)
Figure South America Retinal Biosimilars Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Retinal Biosimilars Growth Rate (2017-2018)
Figure Brazil Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Retinal Biosimilars Growth Rate (2017-2018)
Figure Argentina Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Retinal Biosimilars Growth Rate (2017-2018)
Figure Columbia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Retinal Biosimilars Growth Rate (2017-2018)
Figure Rest of South America Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Retinal Biosimilars Growth Rate (2017-2018)
Figure Middle East and Africa Retinal Biosimilars Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Retinal Biosimilars by Countries (2017-2018)
Figure Middle East and Africa Retinal Biosimilars Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Retinal Biosimilars Growth Rate (2017-2018)
Figure Saudi Arabia Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Retinal Biosimilars Growth Rate (2017-2018)
Figure United Arab Emirates Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Retinal Biosimilars Growth Rate (2017-2018)
Figure Egypt Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Retinal Biosimilars Growth Rate (2017-2018)
Figure Nigeria Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Retinal Biosimilars Growth Rate (2017-2018)
Figure South Africa Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Retinal Biosimilars Growth Rate (2017-2018)
Figure Turkey Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Retinal Biosimilars Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2017-2018)
Table Novartis (Sandoz) Retinal Biosimilars Financial Overview
Table Shire Retinal Biosimilars Financial Overview
Table Bayer Retinal Biosimilars Financial Overview
Table Genentech Retinal Biosimilars Financial Overview
Table Pfenex Retinal Biosimilars Financial Overview
Table Reliance Life Sciences Retinal Biosimilars Financial Overview
Table Hetero Drugs Retinal Biosimilars Financial Overview
Table Intas Pharmaceuticals Retinal Biosimilars Financial Overview
Table Santo Holding Retinal Biosimilars Financial Overview
Table Regeneron Pharmaceuticals Retinal Biosimilars Financial Overview
Figure Global Retinal Biosimilars Revenue (Millions USD) and Growth Rate (2018-2025)
Table Retinal Biosimilars Market Forecast by Regions (2018-2025)
Figure North America Retinal Biosimilars Market Forecast (2018-2025)
Figure United States Retinal Biosimilars Market Forecast (2018-2025)
Figure Canada Retinal Biosimilars Market Forecast (2018-2025)
Figure Mexico Retinal Biosimilars Market Forecast (2018-2025)
Figure Europe Retinal Biosimilars Market Forecast (2018-2025)
Figure Germany Retinal Biosimilars Market Forecast (2018-2025)
Figure France Retinal Biosimilars Market Forecast (2018-2025)
Figure UK Retinal Biosimilars Market Forecast (2018-2025)
Figure Russia Retinal Biosimilars Market Forecast (2018-2025)
Figure Italy Retinal Biosimilars Market Forecast (2018-2025)
Figure Rest of Europe Retinal Biosimilars Market Forecast (2018-2025)
Figure Asia-Pacific Retinal Biosimilars Market Forecast (2018-2025)
Figure China Retinal Biosimilars Market Forecast (2018-2025)
Figure Japan Retinal Biosimilars Market Forecast (2018-2025)
Figure Korea Retinal Biosimilars Market Forecast (2018-2025)
Figure India Retinal Biosimilars Market Forecast (2018-2025)
Figure Southeast Asia Retinal Biosimilars Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Retinal Biosimilars Market Forecast (2018-2025)
Figure South America Retinal Biosimilars Market Forecast (2018-2025)
Figure Brazil Retinal Biosimilars Market Forecast (2018-2025)
Figure Argentina Retinal Biosimilars Market Forecast (2018-2025)
Figure Columbia Retinal Biosimilars Market Forecast (2018-2025)
Figure Rest of South America Retinal Biosimilars Market Forecast (2018-2025)
Figure Middle East and Africa Retinal Biosimilars Market Forecast (2018-2025)
Figure Saudi Arabia Retinal Biosimilars Market Forecast (2018-2025)
Figure United Arab Emirates Retinal Biosimilars Market Forecast (2018-2025)
Figure Egypt Retinal Biosimilars Market Forecast (2018-2025)
Figure Nigeria Retinal Biosimilars Market Forecast (2018-2025)
Figure South Africa Retinal Biosimilars Market Forecast (2018-2025)
Figure Turkey Retinal Biosimilars Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Retinal Biosimilars Market Forecast (2018-2025)
Figure Global Retinal Biosimilars Forecast by Type (2018-2025)
Figure Global Retinal Biosimilars Market Share Forecast by Type (2018-2025)
Figure Global Retinal Biosimilars Forecast by Type (2018-2025)
Figure Global Retinal Biosimilars Forecast by Application (2018-2025)
Figure Global Retinal Biosimilars Market Share Forecast by Application (2018-2025)
Figure Global Retinal Biosimilars Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|